Portfolio
Our partnerships are focused on products that address areas of high unmet medical need.
Livmarli®
Prialt®
Thiotepa Riemser
Cardioplexol®
Please note that packaging and presentation may vary from market to market, and specific regulations may apply to products in some countries.
Transforming orphan drug commercialisation
Find out how our commercialisation solution accelerates impact and powers access to rare disease medicines.
Novel therapies
Accelerate launch trajectories
A comprehensive suite of services designed specifically to support the end-to-end commercialisation needs of biotech and pharmaceutical companies with near-to-market products.
Established brands
Optimise multi-market operations
A selection of services to enable secure access to local markets in a time and resource-efficient manner, including multi-market tender and supply chain management.
Ready to take the next step?
Let us share how we could successfully support your product commercialisation.